{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:50:30Z","timestamp":1792025430117,"version":"4.4.0"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T00:00:00Z","timestamp":1408406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1038\/nrneph.2014.137","type":"journal-article","created":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T12:37:16Z","timestamp":1408451836000},"page":"587-601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Translational research in ADPKD: lessons from animal models"],"prefix":"10.1038","volume":"10","author":[{"given":"Hester","family":"Happ\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien J. M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,19]]},"reference":[{"key":"BFnrneph2014137_CR1","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres, V. E., Harris, P. C. & Pirson, Y. Autosomal dominant polycystic kidney disease. Lancet 369, 1287\u20131301 (2007).","journal-title":"Lancet"},{"key":"BFnrneph2014137_CR2","doi-asserted-by":"crossref","unstructured":"Peters, D. J. M. & Sandkuijl, L. A. Genetic heterogeneity of polycystic kidney disease in Europe. Contrib. Nephrol. 128\u2013139 (1992).","DOI":"10.1159\/000421651"},{"key":"BFnrneph2014137_CR3","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1681\/ASN.2006121387","volume":"18","author":"S Rossetti","year":"2007","unstructured":"Rossetti, S. et al. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 18, 2143\u20132160 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/1471-2369-14-186","volume":"14","author":"V Martinez","year":"2013","unstructured":"Martinez, V. et al. Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry. BMC Nephrol. 14, 186 (2013).","journal-title":"BMC Nephrol."},{"issue":"Suppl. 1","key":"BFnrneph2014137_CR5","first-page":"e1","volume":"57","author":"AJ Collins","year":"2011","unstructured":"Collins, A. J. et al. US Renal Data System 2010 Annual Data Report. Am. J. Kidney Dis. 57 (Suppl. 1), e1\u2013e526 (2011).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2014137_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2215\/CJN.00550110","volume":"5","author":"JJ Grantham","year":"2010","unstructured":"Grantham, J. J., Cook, L. T., Wetzel, L. H., Cadnapaphornchai, M. A. & Bae, K. T. Evidence of extraordinary growth in the progressive enlargement of renal cysts. Clin. J. Am. Soc. Nephrol. 5, 889\u2013896 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","volume":"343","author":"D Ravine","year":"1994","unstructured":"Ravine, D. et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343, 824\u2013827 (1994).","journal-title":"Lancet"},{"key":"BFnrneph2014137_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/1097-0096(200007\/08)28:6<277::AID-JCU2>3.0.CO;2-L","volume":"28","author":"C Nicolau","year":"2000","unstructured":"Nicolau, C. et al. Abdominal sonographic study of autosomal dominant polycystic kidney disease. J. Clin. Ultrasound 28, 277\u2013282 (2000).","journal-title":"J. Clin. Ultrasound"},{"key":"BFnrneph2014137_CR9","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/ndt\/13.11.2825","volume":"13","author":"M Danaci","year":"1998","unstructured":"Danaci, M. et al. The prevalence of seminal vesicle cysts in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 13, 2825\u20132828 (1998).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2014137_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1148\/radiology.180.1.2052727","volume":"180","author":"MB Alpern","year":"1991","unstructured":"Alpern, M. B., Dorfman, R. E., Gross, B. H., Gottlieb, C. A. & Sandler, M. A. Seminal vesicle cysts: association with adult polycystic kidney disease. Radiology 180, 79\u201380 (1991).","journal-title":"Radiology"},{"key":"BFnrneph2014137_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0272-6386(00)70299-X","volume":"35","author":"EF Wijdicks","year":"2000","unstructured":"Wijdicks, E. F., Torres, V. E. & Schievink, W. I. Chronic subdural hematoma in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 35, 40\u201343 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2014137_CR12","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3171\/jns.1995.83.6.1004","volume":"83","author":"WI Schievink","year":"1995","unstructured":"Schievink, W. I., Huston, J. III, Torres, V. E. & Marsh, W. R. Intracranial cysts in autosomal dominant polycystic kidney disease. J. Neurosurg. 83, 1004\u20131007 (1995).","journal-title":"J. Neurosurg."},{"key":"BFnrneph2014137_CR13","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1542\/peds.110.1.e13","volume":"110","author":"FK Alehan","year":"2002","unstructured":"Alehan, F. K., Gurakan, B. & Agildere, M. Familial arachnoid cysts in association with autosomal dominant polycystic kidney disease. Pediatrics 110, e3 (2002).","journal-title":"Pediatrics"},{"key":"BFnrneph2014137_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrneph.2009.13","volume":"5","author":"T Ecder","year":"2009","unstructured":"Ecder, T. & Schrier, R. W. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat. Rev. Nephrol. 5, 221\u2013228 (2009).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2014137_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0092-8674(00)81793-6","volume":"87","author":"FJ Qian","year":"1996","unstructured":"Qian, F. J., Watnick, T. J., Onuchic, L. F. & Germino, G. G. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease. Cell 87, 979\u2013987 (1996).","journal-title":"Cell"},{"key":"BFnrneph2014137_CR16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1681\/ASN.V1071524","volume":"10","author":"Y Pei","year":"1999","unstructured":"Pei, Y. et al. Somatic PKD2 mutations in individual kidney and liver cysts support a \u201ctwo-hit\u201d model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 10, 1524\u20131529 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/75981","volume":"25","author":"T Watnick","year":"2000","unstructured":"Watnick, T. et al. Mutations of PKD 1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations. Nat. Genet. 25, 143\u2013144 (2000).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(05)62286-6","volume":"349","author":"AC Ong","year":"1997","unstructured":"Ong, A. C. & Harris, P. C. Molecular basis of renal cyst formation--one hit or two? Lancet 349, 1039\u20131040 (1997).","journal-title":"Lancet"},{"key":"BFnrneph2014137_CR19","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/hmg\/ddh336","volume":"13","author":"IS Lantinga-van Leeuwen","year":"2004","unstructured":"Lantinga-van Leeuwen, I. S. et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum. Mol. Genet. 13, 3069\u20133077 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR20","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1093\/hmg\/ddp190","volume":"18","author":"H Happ\u00e9","year":"2009","unstructured":"Happ\u00e9, H. et al. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum. Mol. Genet. 18, 2532\u20132542 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1681\/ASN.2007060688","volume":"19","author":"X Wang","year":"2008","unstructured":"Wang, X., Wu, Y., Ward, C. J., Harris, P. C. & Torres, V. E. Vasopressin directly regulates cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 19, 102\u2013108 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000424402","volume":"115","author":"R Torra","year":"1995","unstructured":"Torra, R., Darnell, A., Estivill, X., Botey, A. & Revert, L. Interfamilial and intrafamilial variability of clinical expression in ADPKD. Contrib. Nephrol. 115, 97\u2013101 (1995).","journal-title":"Contrib. Nephrol."},{"key":"BFnrneph2014137_CR23","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall, E. et al. Type of PKD1 mutation influences renal outcome in ADPKD. J. Am. Soc. Nephrol. 24, 1006\u20131013 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer, N. et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353, 103\u2013107 (1999).","journal-title":"Lancet"},{"key":"BFnrneph2014137_CR25","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/S0140-6736(03)13773-7","volume":"361","author":"S Rossetti","year":"2003","unstructured":"Rossetti, S. et al. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361, 2196\u20132201 (2003).","journal-title":"Lancet"},{"key":"BFnrneph2014137_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/ki.2008.686","volume":"75","author":"S Rossetti","year":"2009","unstructured":"Rossetti, S. et al. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int. 75, 848\u2013855 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1681\/ASN.2009101070","volume":"21","author":"M Vujic","year":"2010","unstructured":"Vujic, M. et al. Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. J. Am. Soc. Nephrol. 21, 1097\u20131102 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/jmedgenet-2011-100452","volume":"49","author":"M Losekoot","year":"2012","unstructured":"Losekoot, M. et al. Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy. J. Med. Genet. 49, 37\u201340 (2012).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2014137_CR29","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1681\/ASN.2010101080","volume":"22","author":"C Bergmann","year":"2011","unstructured":"Bergmann, C. et al. Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J. Am. Soc. Nephrol. 22, 2047\u20132056 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR30","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1681\/ASN.V661643","volume":"6","author":"S Geberth","year":"1995","unstructured":"Geberth, S. et al. More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension. J. Am. Soc. Nephrol. 6, 1643\u20131648 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1294-328","volume":"8","author":"PT Brook-Carter","year":"1994","unstructured":"Brook-Carter, P. T. et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease\u2014a contiguous gene syndrome. Nat. Genet. 8, 328\u2013332 (1994).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/5944","volume":"21","author":"W Lu","year":"1999","unstructured":"Lu, W. et al. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat. Genet. 21, 160\u2013161 (1999).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR33","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1073\/pnas.040550097","volume":"97","author":"K Kim","year":"2000","unstructured":"Kim, K., Drummond, I., Ibraghimov-Beskrovnaya, O., Klinger, K. & Arnaout, M. A. Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl Acad. Sci. USA 97, 1731\u20131736 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2014137_CR34","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/hmg\/11.15.1731","volume":"11","author":"S Muto","year":"2002","unstructured":"Muto, S. et al. Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum. Mol. Genet. 11, 1731\u20131742 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR35","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1093\/hmg\/ddm299","volume":"16","author":"IS Lantinga-van Leeuwen","year":"2007","unstructured":"Lantinga-van Leeuwen, I. S. et al. Kidney-specific inactivation of the P kd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum. Mol. Genet. 16, 3188\u20133196 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR36","doi-asserted-by":"publisher","first-page":"F73","DOI":"10.1152\/ajprenal.00362.2007","volume":"294","author":"TA Natoli","year":"2008","unstructured":"Natoli, T. A. et al. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures. Am. J. Physiol. Renal Physiol. 294, F73\u2013F83 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2014137_CR37","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1093\/hmg\/10.21.2385","volume":"10","author":"W Lu","year":"2001","unstructured":"Lu, W. et al. Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum. Mol. Genet. 10, 2385\u20132396 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","volume":"93","author":"G Wu","year":"1998","unstructured":"Wu, G. et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93, 177\u2013188 (1998).","journal-title":"Cell"},{"key":"BFnrneph2014137_CR39","doi-asserted-by":"publisher","first-page":"12174","DOI":"10.1073\/pnas.211191098","volume":"98","author":"C Boulter","year":"2001","unstructured":"Boulter, C. et al. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc. Natl Acad. Sci. USA 98, 12174\u201312179 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2014137_CR40","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0960-9822(02)00869-2","volume":"12","author":"P Pennekamp","year":"2002","unstructured":"Pennekamp, P. et al. The ion channel polycystin-2 is required for left-right axis determination in mice. Curr. Biol. 12, 938\u2013943 (2002).","journal-title":"Curr. Biol."},{"key":"BFnrneph2014137_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/dvg.20207","volume":"44","author":"IS Lantinga-van Leeuwen","year":"2006","unstructured":"Lantinga-van Leeuwen, I. S. et al. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells. Genesis 44, 225\u2013232 (2006).","journal-title":"Genesis"},{"key":"BFnrneph2014137_CR42","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/nm1675","volume":"13","author":"K Piontek","year":"2007","unstructured":"Piontek, K., Menezes, L. F., Garcia-Gonzalez, M. A., Huso, D. L. & Germino, G. G. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat. Med. 13, 1490\u20131495 (2007).","journal-title":"Nat. Med."},{"key":"BFnrneph2014137_CR43","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1097\/01.ASN.0000144204.01352.86","volume":"15","author":"KB Piontek","year":"2004","unstructured":"Piontek, K. B. et al. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J. Am. Soc. Nephrol. 15, 3035\u20133043 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR44","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1681\/ASN.2007101139","volume":"19","author":"A Takakura","year":"2008","unstructured":"Takakura, A., Contrino, L., Beck, A. W. & Zhou, J. Pkd1 inactivation induced in adulthood produces focal cystic disease. J. Am. Soc. Nephrol. 19, 2351\u20132363 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR45","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","volume":"17","author":"S Shibazaki","year":"2008","unstructured":"Shibazaki, S. et al. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum. Mol. Genet. 17, 1505\u20131516 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR46","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1681\/ASN.2009030271","volume":"20","author":"I Kim","year":"2009","unstructured":"Kim, I. et al. Conditional mutation of Pkd2 causes cystogenesis and upregulates \u03b2-catenin. J. Am. Soc. Nephrol. 20, 2556\u20132569 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR47","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/ki.2008.111","volume":"73","author":"PG Starremans","year":"2008","unstructured":"Starremans, P. G. et al. A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5\u2032 end of Pkd1. Kidney Int. 73, 1394\u20131405 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR48","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","volume":"17","author":"V Patel","year":"2008","unstructured":"Patel, V. et al. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet. 17, 1578\u20131590 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR49","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/ki.2008.659","volume":"75","author":"KL Raphael","year":"2009","unstructured":"Raphael, K. L. et al. Inactivation of Pkd1 in principal cells causes a more severe cystic kidney disease than in intercalated cells. Kidney Int. 75, 626\u2013633 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/labinvest.2010.159","volume":"91","author":"S Hassane","year":"2011","unstructured":"Hassane, S. et al. Pkd1-inactivation in vascular smooth muscle cells and adaptation to hypertension. Lab. Invest. 91, 24\u201332 (2011).","journal-title":"Lab. Invest."},{"key":"BFnrneph2014137_CR51","doi-asserted-by":"publisher","first-page":"e12821","DOI":"10.1371\/journal.pone.0012821","volume":"5","author":"MA Garcia-Gonzalez","year":"2010","unstructured":"Garcia-Gonzalez, M. A. et al. Pkd1 and Pkd2 are required for normal placental development. PLoS ONE 5, e12821 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrneph2014137_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1681\/ASN.2012050486","volume":"25","author":"D Liu","year":"2013","unstructured":"Liu, D. et al. A Pkd1\u2013Fbn1 genetic interaction implicates TGF-\u03b2 signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 25, 81\u201391 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR53","doi-asserted-by":"publisher","first-page":"18688","DOI":"10.1073\/pnas.0708217104","volume":"104","author":"S Yu","year":"2007","unstructured":"Yu, S. et al. Essential role of cleavage of polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure. Proc. Natl Acad. Sci. USA 104, 18688\u201318693 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2014137_CR54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2353\/ajpath.2006.050342","volume":"168","author":"ST Jiang","year":"2006","unstructured":"Jiang, S. T. et al. Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1. Am. J. Pathol. 168, 205\u2013220 (2006).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2014137_CR55","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1172\/JCI64313","volume":"122","author":"K Hopp","year":"2012","unstructured":"Hopp, K. et al. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J. Clin. Invest. 122, 4257\u20134273 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2014137_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/ng812","volume":"30","author":"BJ Herron","year":"2002","unstructured":"Herron, B. J. et al. Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis. Nat. Genet. 30, 185\u2013189 (2002).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR57","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/hmg\/9.18.2617","volume":"9","author":"L Pritchard","year":"2000","unstructured":"Pritchard, L. et al. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum. Mol. Genet. 9, 2617\u20132627 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR58","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/hmg\/ddp588","volume":"19","author":"A Kurbegovic","year":"2010","unstructured":"Kurbegovic, A. et al. Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes. Hum. Mol. Genet. 19, 1174\u20131189 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR59","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.1074\/jbc.M805890200","volume":"284","author":"EY Park","year":"2009","unstructured":"Park, E. Y. et al. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice. J. Biol. Chem. 284, 7214\u20137222 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2014137_CR60","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1093\/hmg\/ddt081","volume":"22","author":"A Kurbegovic","year":"2013","unstructured":"Kurbegovic, A. & Trudel, M. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain. Hum. Mol. Genet. 22, 2361\u20132375 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR61","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/path.2765","volume":"222","author":"E Wang","year":"2010","unstructured":"Wang, E. et al. Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1. J. Pathol. 222, 238\u2013248 (2010).","journal-title":"J. Pathol."},{"key":"BFnrneph2014137_CR62","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/ng833","volume":"30","author":"CJ Ward","year":"2002","unstructured":"Ward, C. J. et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 30, 259\u2013269 (2002).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR63","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1681\/ASN.2010111173","volume":"22","author":"JL Bakeberg","year":"2011","unstructured":"Bakeberg, J. L. et al. Epitope-tagged Pkhd1 tracks the processing, secretion, and localization of fibrocystin. J. Am. Soc. Nephrol. 22, 2266\u20132277 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR64","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ng.860","volume":"43","author":"SV Fedeles","year":"2011","unstructured":"Fedeles, S. V. et al. A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Nat. Genet. 43, 639\u2013647 (2011).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR65","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/sj.ki.5002294","volume":"72","author":"JR Woollard","year":"2007","unstructured":"Woollard, J. R. et al. A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation. Kidney Int. 72, 328\u2013336 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR66","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2353\/ajpath.2008.070381","volume":"172","author":"AR Gallagher","year":"2008","unstructured":"Gallagher, A. R. et al. Biliary and pancreatic dysgenesis in mice harboring a mutation in Pk hd1. Am. J. Pathol. 172, 417\u2013429 (2008).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2014137_CR67","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1681\/ASN.2007070770","volume":"19","author":"I Kim","year":"2008","unstructured":"Kim, I. et al. Fibrocystin\/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. J. Am. Soc. Nephrol. 19, 455\u2013468 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.yexcr.2010.09.012","volume":"317","author":"B Hu","year":"2011","unstructured":"Hu, B. et al. Cystogenesis in ARPKD results from increased apoptosis in collecting duct epithelial cells of Pkhd1 mutant kidneys. Exp. Cell Res. 317, 173\u2013187 (2011).","journal-title":"Exp. Cell Res."},{"key":"BFnrneph2014137_CR69","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/hep.20655","volume":"41","author":"M Moser","year":"2005","unstructured":"Moser, M. et al. A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD). Hepatology 41, 1113\u20131121 (2005).","journal-title":"Hepatology"},{"key":"BFnrneph2014137_CR70","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00467-007-0735-4","volume":"23","author":"SS Williams","year":"2008","unstructured":"Williams, S. S., Cobo-Stark, P., James, L. R., Somlo, S. & Igarashi, P. Kidney cysts, pancreatic cysts, and biliary disease in a mouse model of autosomal recessive polycystic kidney disease. Pediatr. Nephrol. 23, 733\u2013741 (2008).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2014137_CR71","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/hmg\/ddm141","volume":"16","author":"MA Garcia-Gonzalez","year":"2007","unstructured":"Garcia-Gonzalez, M. A. et al. Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway. Hum. Mol. Genet. 16, 1940\u20131950 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR72","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1097\/01.ASN.0000030392.19694.9D","volume":"13","author":"Y Nagasawa","year":"2002","unstructured":"Nagasawa, Y. et al. Identification and characterization of Pkhd1, the mouse orthologue of the human ARPKD gene. J. Am. Soc. Nephrol. 13, 2246\u20132258 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR73","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/ng1217","volume":"34","author":"EA Otto","year":"2003","unstructured":"Otto, E. A. et al. Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination. Nat. Genet. 34, 413\u2013420 (2003).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR74","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1681\/ASN.2007040490","volume":"19","author":"EA Otto","year":"2008","unstructured":"Otto, E. A. et al. NEK8 mutations affect ciliary and centrosomal localization and may cause nephronophthisis. J. Am. Soc. Nephrol. 19, 587\u2013592 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR75","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1242\/dev.00173","volume":"129","author":"S Liu","year":"2002","unstructured":"Liu, S. et al. A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish. Development 129, 5839\u20135846 (2002).","journal-title":"Development"},{"key":"BFnrneph2014137_CR76","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/ng1216","volume":"34","author":"H Olbrich","year":"2003","unstructured":"Olbrich, H. et al. Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis. Nat. Genet. 34, 455\u2013459 (2003).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR77","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1097\/01.ASN.0000131520.07008.B3","volume":"15","author":"CL Phillips","year":"2004","unstructured":"Phillips, C. L. et al. Renal cysts of inv\/i nv mice resemble early infantile nephronophthisis. J. Am. Soc. Nephrol. 15, 1744\u20131755 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR78","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V17980","volume":"1","author":"H Takahashi","year":"1991","unstructured":"Takahashi, H. et al. A hereditary model of slowly progressive polycystic kidney disease in the mouse. J. Am. Soc. Nephrol. 1, 980\u2013989 (1991).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR79","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/humu.21610","volume":"33","author":"MR Kraus","year":"2012","unstructured":"Kraus, M. R. et al. Two mutations in human BICC1 resulting in Wnt pathway hyperactivity associated with cystic renal dysplasia. Hum. Mutat. 33, 86\u201390 (2012).","journal-title":"Hum. Mutat."},{"key":"BFnrneph2014137_CR80","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/ki.1996.423","volume":"50","author":"LM Guay-Woodford","year":"1996","unstructured":"Guay-Woodford, L. M. et al. Evidence that two phenotypically distinct mouse PKD mutations, b pk and jcpk, are allelic. Kidney Int. 50, 1158\u20131165 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR81","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm1004","volume":"10","author":"VE Torres","year":"2004","unstructured":"Torres, V. E. et al. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat. Med. 10, 363\u2013364 (2004).","journal-title":"Nat. Med."},{"key":"BFnrneph2014137_CR82","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm935","volume":"9","author":"VH Gattone","year":"2003","unstructured":"Gattone, V. H., Wang, X., Harris, P. C. & Torres, V. E. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat. Med. 9, 1323\u20131326 (2003).","journal-title":"Nat. Med."},{"key":"BFnrneph2014137_CR83","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","volume":"16","author":"X Wang","year":"2005","unstructured":"Wang, X., Gattone, V. II, Harris, P. C. & Torres, V. E. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J . Am. Soc. Nephrol. 16, 846\u2013851 (2005).","journal-title":"J . Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR84","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1093\/ndt\/gfr069","volume":"26","author":"E Meijer","year":"2011","unstructured":"Meijer, E. et al. Therapeutic potential of a vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. Nephrol . Dial. Transplant. 26, 2445\u20132453 (2011).","journal-title":"Nephrol . Dial. Transplant."},{"key":"BFnrneph2014137_CR85","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","volume":"64","author":"VE Torres","year":"2003","unstructured":"Torres, V. E. et al. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int. 64, 1573\u20131579 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR86","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1111\/j.1523-1755.2004.00952.x","volume":"66","author":"VE Torres","year":"2004","unstructured":"Torres, V. E. et al. Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats. Kidney Int. 66, 1766\u20131773 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR87","doi-asserted-by":"publisher","first-page":"31559","DOI":"10.1074\/jbc.M805452200","volume":"283","author":"I Kim","year":"2008","unstructured":"Kim, I. et al. Polycystin-2 expression is regulated by a PC2-binding domain in the intracellular portion of fibrocystin. J. Biol. Chem. 283, 31559\u201331566 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2014137_CR88","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/ki.2013.13","volume":"83","author":"H Happ\u00e9","year":"2013","unstructured":"Happ\u00e9, H. et al. Cyst expansion and regression in a mouse model of polycystic kidney disease. Kidney Int. 83, 1099\u20131108 (2013).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR89","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1161\/ATVBAHA.107.149252","volume":"27","author":"S Hassane","year":"2007","unstructured":"Hassane, S. et al. Pathogenic sequence for dissecting aneurysm formation in a hypomorphic polycystic kidney disease 1 mouse model. Arterioscler. Thromb. Vasc. Biol. 27, 2177\u20132183 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph2014137_CR90","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1053\/ajkd.2001.27694","volume":"38","author":"MM Belz","year":"2001","unstructured":"Belz, M. M. et al. Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 38, 770\u2013776 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2014137_CR91","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ng1097-179","volume":"17","author":"W Lu","year":"1997","unstructured":"Lu, W. et al. Perinatal lethality with kidney and pancreas defects, in mice with a targeted pkd1 mutation. Nat. Genet. 17, 179\u2013181 (1997).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR92","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1086\/318188","volume":"68","author":"Y Pei","year":"2001","unstructured":"Pei, Y. et al. Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease. Am. J. Hum. Genet. 68, 355\u2013363 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2014137_CR93","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/hmg\/11.16.1845","volume":"11","author":"G Wu","year":"2002","unstructured":"Wu, G. et al. Trans-heterozygous Pkd1 and Pk d2 mutations modify expression of polycystic kidney disease. Hum. Mol. Genet. 11, 1845\u20131854 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR94","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1128\/MCB.26.4.1538-1548.2006","volume":"26","author":"C Thivierge","year":"2006","unstructured":"Thivierge, C. et al. Overexpression of PKD1 causes polycystic kidney disease. Mol. Cell Biol. 26, 1538\u20131548 (2006).","journal-title":"Mol. Cell Biol."},{"key":"BFnrneph2014137_CR95","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/ndt\/gfm763","volume":"23","author":"S Burtey","year":"2008","unstructured":"Burtey, S. et al. Overexpression of PKD2 in the mouse is associated with renal tubulopathy. Nephrol. Dial. Transplant. 23, 1157\u20131165 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2014137_CR96","doi-asserted-by":"publisher","first-page":"11276","DOI":"10.1074\/jbc.M110483200","volume":"277","author":"P Delmas","year":"2002","unstructured":"Delmas, P. et al. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J . Biol. Chem. 277, 11276\u201311283 (2002).","journal-title":"J . Biol. Chem."},{"key":"BFnrneph2014137_CR97","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cell.2009.08.045","volume":"109","author":"R Sharif-Naeini","year":"2009","unstructured":"Sharif-Naeini, R. et al. Polycystin-1 and -2 dosage regulates pressure sensing. Cell 109, 587\u2013596 (2009).","journal-title":"Cell"},{"key":"BFnrneph2014137_CR98","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.celrep.2012.01.006","volume":"1","author":"R Peyronnet","year":"2012","unstructured":"Peyronnet, R. et al. Mechanoprotection by polycystins against apoptosis is mediated through the opening of stretch-activated K2P channels. Cell Reports 1, 241\u2013250 (2012).","journal-title":"Cell Reports"},{"key":"BFnrneph2014137_CR99","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1093\/hmg\/ddt031","volume":"22","author":"AJ Streets","year":"2013","unstructured":"Streets, A. J., Wessely, O., Peters, D. J. & Ong, A. C. Hyperphosphorylation of polycystin-2 at a critical residue in disease reveals an essential role for polycystin-1 mediated dephosphorylation. Hum. Mol. Genet. 22, 1924\u20131939 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR100","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1046\/j.1523-1755.2000.00433.x","volume":"58","author":"C Sise","year":"2000","unstructured":"Sise, C. et al. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney Int. 58, 2492\u20132501 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR101","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2215\/CJN.00330705","volume":"1","author":"JJ Grantham","year":"2006","unstructured":"Grantham, J. J., Chapman, A. B. & Torres, V. E. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin. J. Am. Soc. Nephrol. 1, 148\u2013157 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR102","unstructured":"Leonhard, W. N. et al. Scattered deletion of Pkd1 in mouse kidneys causes a cystic snowball effect and recapitulates human polycystic kidney disease. J. Am. Soc. Nephrol. (in press)."},{"key":"BFnrneph2014137_CR103","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1172\/JCI22850","volume":"115","author":"S Nishio","year":"2005","unstructured":"Nishio, S. et al. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J. Clin. Invest. 115, 910\u2013918 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2014137_CR104","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2353\/ajpath.2009.090227","volume":"175","author":"S Prasad","year":"2009","unstructured":"Prasad, S., McDaid, J. P., Tam, F. W., Haylor, J. L. & Ong, A. C. Pkd2 dosage influences cellular repair responses following ischemia\u2013reperfusion injury. Am. J. Pathol. 175, 1493\u20131503 (2009).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2014137_CR105","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1681\/ASN.2008040435","volume":"20","author":"AP Bastos","year":"2009","unstructured":"Bastos, A. P. et al. Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia\/reperfusion. J. Am. Soc. Nephrol. 20, 2389\u20132402 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR106","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1093\/hmg\/ddp147","volume":"18","author":"A Takakura","year":"2009","unstructured":"Takakura, A. et al. Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum. Mol. Genet. 18, 2523\u20132531 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR107","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1681\/ASN.2012020154","volume":"24","author":"N Sharma","year":"2013","unstructured":"Sharma, N. et al. Proximal tubule proliferation is insufficient to induce rapid cyst formation after cilia disruption. J. Am. Soc. Nephrol. 24, 456\u2013464 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-14-1","volume":"14","author":"JH Hwang","year":"2013","unstructured":"Hwang, J. H. et al. Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease. BMC Nephrol. 14, 1 (2013).","journal-title":"BMC Nephrol."},{"key":"BFnrneph2014137_CR109","doi-asserted-by":"publisher","first-page":"278","DOI":"10.7861\/clinmedicine.9-3-278","volume":"9","author":"CL Chow","year":"2009","unstructured":"Chow, C. L. & Ong, A. C. Autosomal dominant polycystic kidney disease. Clin. Med. 9, 278\u2013283 (2009).","journal-title":"Clin. Med."},{"key":"BFnrneph2014137_CR110","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.arr.2014.02.003","volume":"14","author":"D Bolignano","year":"2014","unstructured":"Bolignano, D., Mattace-Raso, F., Sijbrands, E. J. & Zoccali, C. The aging kidney revisited: a systematic review. Ageing Res. Rev. 14, 65\u201380 (2014).","journal-title":"Ageing Res. Rev."},{"key":"BFnrneph2014137_CR111","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/sj.emboj.7600160","volume":"23","author":"L Gresh","year":"2004","unstructured":"Gresh, L. et al. A transcriptional network in polycystic kidney disease. EMBO J. 23, 1657\u20131668 (2004).","journal-title":"EMBO J."},{"key":"BFnrneph2014137_CR112","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1172\/JCI200420083","volume":"113","author":"T Hiesberger","year":"2004","unstructured":"Hiesberger, T. et al. Mutation of hepatocyte nuclear factor-1\u03b2 inhibits Pkhd1 gene expression and produces renal cysts in mice. J. Clin. Invest. 113, 814\u2013825 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2014137_CR113","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1242\/dev.046045","volume":"137","author":"U Tran","year":"2010","unstructured":"Tran, U. et al. The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing mi R-17 activity. Development 137, 1107\u20131116 (2010).","journal-title":"Development"},{"key":"BFnrneph2014137_CR114","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ng0697-179","volume":"16","author":"F Qian","year":"1997","unstructured":"Qian, F. et al. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat. Genet. 16, 179\u2013183 (1997).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR115","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.1073\/pnas.94.13.6965","volume":"94","author":"L Tsiokas","year":"1997","unstructured":"Tsiokas, L., Kim, E., Arnould, T., Sukhatme, V. P. & Walz, G. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc. Natl Acad. Sci. USA 94, 6965\u20136970 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2014137_CR116","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1104","volume":"33","author":"JP Drenth","year":"2003","unstructured":"Drenth, J. P., Te Morsche, R. H., Smink, R., Bonifacino, J. S. & Jansen, J. B. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat. Genet. 33, 345\u2013347 (2003).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR117","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1086\/368295","volume":"72","author":"A Li","year":"2003","unstructured":"Li, A. et al. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am. J. Hum. Genet. 72, 691\u2013703 (2003).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2014137_CR118","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ng1357","volume":"36","author":"S Davila","year":"2004","unstructured":"Davila, S. et al. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat. Genet. 36, 575\u2013577 (2004).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR119","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ncb2040","volume":"12","author":"B Guirao","year":"2010","unstructured":"Guirao, B. et al. Coupling between hydrodynamic forces and planar cell polarity orients mammalian motile cilia. Nat. Cell Biol. 12, 341\u2013350 (2010).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneph2014137_CR120","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.bbadis.2011.05.005","volume":"1812","author":"H Happ\u00e9","year":"2011","unstructured":"Happ\u00e9, H., de Heer, E. & Peters, D. J. Polycystic kidney disease: the complexity of planar cell polarity and signaling during tissue regeneration and cyst formation. Biochim. Biophys. Acta 1812, 1249\u20131255 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph2014137_CR121","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.2715","volume":"45","author":"M Ma","year":"2013","unstructured":"Ma, M., Tian, X., Igarashi, P., Pazour, G. J. & Somlo, S. Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat. Genet. 45, 1004\u20131012 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR122","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1076","volume":"33","author":"SM Nauli","year":"2003","unstructured":"Nauli, S. M. et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33, 129\u2013137 (2003).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR123","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/ng1552","volume":"37","author":"M Simons","year":"2005","unstructured":"Simons, M. et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat. Genet. 37, 537\u2013543 (2005).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR124","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/ncb2117","volume":"12","author":"C Boehlke","year":"2010","unstructured":"Boehlke, C. et al. Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat. Cell Biol. 12, 1115\u20131122 (2010).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneph2014137_CR125","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/ng0505-455","volume":"37","author":"GG Germino","year":"2005","unstructured":"Germino, G. G. Linking cilia to Wnts. Nat. Genet. 37, 455\u2013457 (2005).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR126","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ng1701","volume":"38","author":"E Fischer","year":"2006","unstructured":"Fischer, E. et al. Defective planar cell polarity in polycystic kidney disease. Nat. Genet. 38, 21\u201323 (2006).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR127","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1083\/jcb.200808137","volume":"183","author":"JA Jonassen","year":"2008","unstructured":"Jonassen, J. A., San, A. J., Follit, J. A. & Pazour, G. J. Deletion of IFT20 in the mouse kidney causes misorientation of the mitotic spindle and cystic kidney disease. J. Cell Biol. 183, 377\u2013384 (2008).","journal-title":"J. Cell Biol."},{"key":"BFnrneph2014137_CR128","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nm.2068","volume":"16","author":"F Verdeguer","year":"2010","unstructured":"Verdeguer, F. et al. A mitotic transcriptional switch in polycystic kidney disease. Nat. Med. 16, 106\u2013110 (2010).","journal-title":"Nat. Med."},{"key":"BFnrneph2014137_CR129","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1681\/ASN.2010010127","volume":"21","author":"A Luyten","year":"2010","unstructured":"Luyten, A. et al. Aberrant regulation of planar cell polarity in polycystic kidney disease. J. Am . Soc. Nephrol. 21, 1521\u20131532 (2010).","journal-title":"J. Am . Soc. Nephrol."},{"key":"BFnrneph2014137_CR130","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/ng.179","volume":"40","author":"S Saburi","year":"2008","unstructured":"Saburi, S. et al. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease. Nat. Genet. 40, 1010\u20131015 (2008).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR131","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1681\/ASN.2009060603","volume":"21","author":"S Nishio","year":"2010","unstructured":"Nishio, S. et al. Loss of oriented cell division does not initiate cyst formation. J. Am. Soc. Nephrol. 21, 295\u2013302 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR132","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/ki.1992.413","volume":"42","author":"M Zeier","year":"1992","unstructured":"Zeier, M. et al. Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int. 42, 1259\u20131265 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR133","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1523-1755.2000.00205.x","volume":"58","author":"H Okada","year":"2000","unstructured":"Okada, H. et al. Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int. 58, 587\u2013597 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR134","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0011-5029(05)80007-0","volume":"41","author":"JR Martinez","year":"1995","unstructured":"Martinez, J. R. & Grantham, J. J. Polycystic kidney disease: etiology, pathogenesis, and treatment. Dis. Mon. 41, 693\u2013765 (1995).","journal-title":"Dis. Mon."},{"key":"BFnrneph2014137_CR135","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1681\/ASN.2011010084","volume":"22","author":"A Karihaloo","year":"2011","unstructured":"Karihaloo, A. et al. Macrophages promote cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 22, 1809\u20131814 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR136","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ki.2012.446","volume":"83","author":"KI Swenson-Fields","year":"2013","unstructured":"Swenson-Fields, K. I. et al. Macrophages promote polycystic kidney disease progression. Kidney Int. 83, 855\u2013864 (2013).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR137","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.ki.5002627","volume":"73","author":"M Mrug","year":"2008","unstructured":"Mrug, M. et al. Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int. 73, 63\u201376 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR138","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/sj.ki.5002658","volume":"73","author":"E De Heer","year":"2008","unstructured":"De Heer, E. & Peters, D. J. Innate immunity as a driving force in renal disease. Kidney Int. 73, 7\u20138 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR139","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/nep.12045","volume":"18","author":"MH Ta","year":"2013","unstructured":"Ta, M. H., Harris, D. C. & Rangan, G. K. Role of interstitial inflammation in the pathogenesis of polycystic kidney disease. Nephrology (Carlton) 18, 317\u2013330 (2013).","journal-title":"Nephrology (Carlton)"},{"key":"BFnrneph2014137_CR140","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.bbadis.2011.03.003","volume":"1812","author":"IA Drummond","year":"2011","unstructured":"Drummond, I. A. Polycystins, focal adhesions and extracellular matrix interactions. Biochim. Biophys. Acta 1812, 1322\u20131326 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph2014137_CR141","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbadis.2011.02.008","volume":"1812","author":"K Lee","year":"2011","unstructured":"Lee, K., Battini, L. & Gusella, G. L. Cilium, centrosome and cell cycle regulation in polycystic kidney disease. Biochim. Biophys. Acta 1812, 1263\u20131271 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph2014137_CR142","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nm.3092","volume":"19","author":"I Rowe","year":"2013","unstructured":"Rowe, I. et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat. Med. 19, 488\u2013493 (2013).","journal-title":"Nat. Med."},{"key":"BFnrneph2014137_CR143","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","volume":"63","author":"T Yamaguchi","year":"2003","unstructured":"Yamaguchi, T. et al. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int. 63, 1983\u20131994 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR144","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1074\/jbc.273.11.6013","volume":"273","author":"T Arnould","year":"1998","unstructured":"Arnould, T. et al. The polycystic kidney disease 1 gene product mediates protein kinase C \u03b1-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J. Biol. Chem. 273, 6013\u20136018 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2014137_CR145","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1006\/bbrc.1998.9514","volume":"251","author":"SC Parnell","year":"1998","unstructured":"Parnell, S. C. et al. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem. Biophys. Res. Commun. 251, 625\u2013631 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph2014137_CR146","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","volume":"109","author":"AK Bhunia","year":"2002","unstructured":"Bhunia, A. K. et al. PKD1 induces p21waf1 and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 109, 157\u2013168 (2002).","journal-title":"Cell"},{"key":"BFnrneph2014137_CR147","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1681\/ASN.2005050534","volume":"17","author":"M Boca","year":"2006","unstructured":"Boca, M. et al. Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase\/Akt signaling pathway. J. Am. Soc. Nephrol. 17, 637\u2013647 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR148","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford, J. M. et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA 103, 5466\u20135471 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2014137_CR149","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/ndt\/gfq384","volume":"26","author":"C Renken","year":"2010","unstructured":"Renken, C., Fischer, D. C., Kundt, G., Gretz, N. & Haffner, D. Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats. Nephrol. Dial. Transplant. 26, 92\u2013100 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2014137_CR150","doi-asserted-by":"publisher","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","volume":"300","author":"WN Leonhard","year":"2011","unstructured":"Leonhard, W. N. et al. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model. Am. J. Physiol. Renal Physiol. 300, F1193\u2013F1202 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2014137_CR151","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","volume":"18","author":"X Song","year":"2009","unstructured":"Song, X. et al. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum. Mol. Genet. 18, 2328\u20132343 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR152","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1093\/hmg\/ddn208","volume":"17","author":"M Lal","year":"2008","unstructured":"Lal, M. et al. Polycystin-1 C-terminal tail associates with \u03b2-catenin and inhibits canonical Wnt signaling. Hum. Mol. Genet. 17, 3105\u20133117 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR153","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/path.2856","volume":"224","author":"H Happ\u00e9","year":"2011","unstructured":"Happ\u00e9, H. et al. Altered Hippo signalling in polycystic kidney disease. J. Pathol. 224, 133\u2013142 (2011).","journal-title":"J. Pathol."},{"key":"BFnrneph2014137_CR154","doi-asserted-by":"publisher","first-page":"F1423","DOI":"10.1152\/ajprenal.00275.2007","volume":"293","author":"T Weimbs","year":"2007","unstructured":"Weimbs, T. Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1. Am. J. Physiol. Renal Physiol. 293, F1423\u2013F1432 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2014137_CR155","doi-asserted-by":"publisher","first-page":"c25","DOI":"10.1159\/000334166","volume":"120","author":"MY Chang","year":"2012","unstructured":"Chang, M. Y. & Ong, A. C. Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects. Nephron Clin. Pract. 120, c25\u2013c34 (2012).","journal-title":"Nephron Clin. Pract."},{"key":"BFnrneph2014137_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000112495","volume":"108","author":"MY Chang","year":"2008","unstructured":"Chang, M. Y. & Ong, A. C. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment. Nephron Physiol. 108, 1\u20137 (2008).","journal-title":"Nephron Physiol."},{"key":"BFnrneph2014137_CR157","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres, V. E. & Harris, P. C. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 76, 149\u2013168 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR158","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00018-012-1052-z","volume":"70","author":"J Pan","year":"2013","unstructured":"Pan, J., Seeger-Nukpezah, T. & Golemis, E. A. The role of the cilium in normal and abnormal cell cycles: emphasis on renal cystic pathologies. Cell. Mol. Life Sci. 70, 1849\u20131874 (2013).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrneph2014137_CR159","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2796.2006.01743.x","volume":"261","author":"VE Torres","year":"2007","unstructured":"Torres, V. E. & Harris, P. C. Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities. J. Intern. Med. 261, 17\u201331 (2007).","journal-title":"J. Intern. Med."},{"key":"BFnrneph2014137_CR160","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz, G. et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 830\u2013840 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2014137_CR161","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra, A. L. et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 820\u2013829 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2014137_CR162","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1681\/ASN.2009121291","volume":"21","author":"MC Hogan","year":"2010","unstructured":"Hogan, M. C. et al. randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J. Am. Soc. Nephrol. 21, 1052\u20131061 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR163","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","volume":"68","author":"P Ruggenenti","year":"2005","unstructured":"Ruggenenti, P. et al. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int. 68, 206\u2013216 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR164","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres, V. E. et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 367, 2407\u20132418 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2014137_CR165","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","volume":"137","author":"L van Keimpema","year":"2009","unstructured":"van Keimpema, L. et al. Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology 137, 1661\u20131668 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrneph2014137_CR166","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","volume":"382","author":"A Caroli","year":"2013","unstructured":"Caroli, A. et al. Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet 382, 1485\u20131495 (2013).","journal-title":"Lancet"},{"key":"BFnrneph2014137_CR167","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2014)."},{"key":"BFnrneph2014137_CR168","unstructured":"US National Library of Medicine. ClinicalTrials.g ov [online] , (2014)."},{"key":"BFnrneph2014137_CR169","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0700499104","volume":"104","author":"SJ Leuenroth","year":"2007","unstructured":"Leuenroth, S. J. et al. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc. Natl Acad. Sci. USA 104, 4389\u20134394 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2014137_CR170","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/71724","volume":"24","author":"G Wu","year":"2000","unstructured":"Wu, G. et al. Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat. Genet. 24, 75\u201378 (2000).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR171","doi-asserted-by":"publisher","first-page":"e7137","DOI":"10.1371\/journal.pone.0007137","volume":"4","author":"C Wodarczyk","year":"2009","unstructured":"Wodarczyk, C. et al. A novel mouse model reveals that polycystin-1 deficiency in ependyma and choroid plexus results in dysfunctional cilia and hydrocephalus. PLoS ONE 4, e7137 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrneph2014137_CR172","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/hmg\/ddt041","volume":"22","author":"RH Khonsari","year":"2013","unstructured":"Khonsari, R. H. et al. Multiple postnatal craniofacial anomalies are characterized by conditional loss of polycystic kidney disease 2 (Pkd 2). Hum. Mol. Genet. 22, 1873\u20131885 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR173","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2009.09.005","volume":"138","author":"C Spirli","year":"2010","unstructured":"Spirli, C. et al. ERK1\/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice. Gastroenterology 138, 360\u2013371 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrneph2014137_CR174","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nm.2171","volume":"16","author":"TA Natoli","year":"2010","unstructured":"Natoli, T. A. et al. Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models. Nat. Med. 16, 788\u2013792 (2010).","journal-title":"Nat. Med."},{"key":"BFnrneph2014137_CR175","doi-asserted-by":"publisher","first-page":"F870","DOI":"10.1152\/ajprenal.00153.2003","volume":"285","author":"RB Thomson","year":"2003","unstructured":"Thomson, R. B. et al. Histopathological analysis of renal cystic epithelia in the Pkd2WS25\/\u2212 mouse model of ADPKD. Am. J. Physiol. Renal Physiol. 285, F870\u2013F880 (2003).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2014137_CR176","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1681\/ASN.2005090979","volume":"17","author":"AR Gallagher","year":"2006","unstructured":"Gallagher, A. R. et al. A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats. J. Am. Soc. Nephrol. 17, 2719\u20132730 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR177","unstructured":"Mouse Genome Informatics. informat ics.jax.org [online] , (2014)."},{"key":"BFnrneph2014137_CR178","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1538\/expanim.49.51","volume":"49","author":"M Katsuyama","year":"2000","unstructured":"Katsuyama, M., Masuyama, T., Komura, I., Hibino, T. & Takahashi, H. Characterization of a novel polycystic kidney rat model with accompanying polycystic liver. Exp. Anim. 49, 51\u201355 (2000).","journal-title":"Exp. Anim."},{"key":"BFnrneph2014137_CR179","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1046\/j.1523-1755.2001.00473.x","volume":"59","author":"DJ Lager","year":"2001","unstructured":"Lager, D. J., Qian, Q., Bengal, R. J., Ishibashi, M. & Torres, V. E. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease. Kidney Int. 59, 126\u2013136 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR180","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00041552-200205000-00007","volume":"11","author":"PC Harris","year":"2002","unstructured":"Harris, P. C. Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1. Curr. Opin. Nephrol. Hypertens. 11, 309\u2013314 (2002).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph2014137_CR181","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1242\/dev.129.8.1829","volume":"129","author":"C Coffinier","year":"2002","unstructured":"Coffinier, C. et al. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1\u03b2. Development 129, 1829\u20131838 (2002).","journal-title":"Development"},{"key":"BFnrneph2014137_CR182","doi-asserted-by":"publisher","first-page":"10765","DOI":"10.1073\/pnas.1301693110","volume":"110","author":"V Patel","year":"2013","unstructured":"Patel, V. et al. miR-17\u223c92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease. Proc. Natl Acad. Sci. USA 110, 10765\u201310770 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2014137_CR183","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1242\/dev.126.21.4785","volume":"126","author":"C Coffinier","year":"1999","unstructured":"Coffinier, C., Thepot, D., Babinet, C., Yaniv, M. & Barra, J. Essential role for the homeoprotein vHNF1\/HNF1\u03b2 in visceral endoderm differentiation. Development 126, 4785\u20134794 (1999).","journal-title":"Development"},{"key":"BFnrneph2014137_CR184","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/ng1297-384","volume":"17","author":"Y Horikawa","year":"1997","unstructured":"Horikawa, Y. et al. Mutation in hepatocyte nuclear factor-1 \u03b2 gene (TCF2) associated with MODY. Nat. Genet. 17, 384\u2013385 (1997).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR185","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF00864387","volume":"7","author":"J Nauta","year":"1993","unstructured":"Nauta, J., Ozawa, Y., Sweeney, W. E. Jr, Rutledge, J. C. & Avner, E. D. Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease. Pediatr. Nephrol. 7, 163\u2013172 (1993).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2014137_CR186","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/ki.1995.69","volume":"47","author":"L Flaherty","year":"1995","unstructured":"Flaherty, L., Bryda, E. C., Collins, D., Rudofsky, U. & Montogomery, J. C. New mouse model for polycystic kidney disease with both recessive and dominant gene effects. Kidney Int. 47, 552\u2013558 (1995).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR187","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1172\/JCI0214099","volume":"109","author":"X Hou","year":"2002","unstructured":"Hou, X. et al. Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease. J. Clin. Invest. 109, 533\u2013540 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2014137_CR188","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1681\/ASN.V11101837","volume":"11","author":"JL Ricker","year":"2000","unstructured":"Ricker, J. L., Gattone, V. H., Calvet, J. P. & Rankin, C. A. Development of autosomal recessive polycystic kidney disease in BALB\/c-cpk\/cpk mice. J. Am. Soc. Nephrol. 11, 1837\u20131847 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR189","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.8480178","volume":"260","author":"T Yokoyama","year":"1993","unstructured":"Yokoyama, T. et al. Reversal of left-right asymmetry: a situs inversus mutation. Science 260, 679\u2013682 (1993).","journal-title":"Science"},{"key":"BFnrneph2014137_CR190","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/2450","volume":"20","author":"D Morgan","year":"1998","unstructured":"Morgan, D. et al. Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouse. Nat. Genet. 20, 149\u2013156 (1998).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR191","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/26006","volume":"395","author":"T Mochizuki","year":"1998","unstructured":"Mochizuki, T. et al. Cloning of inv, a gene that controls left\/right asymmetry and kidney development. Nature 395, 177\u2013181 (1998).","journal-title":"Nature"},{"key":"BFnrneph2014137_CR192","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/S0022-5347(17)46074-5","volume":"135","author":"H Takahashi","year":"1986","unstructured":"Takahashi, H. et al. A new mouse model of genetically transmitted polycystic kidney disease. J. Urol. 135, 1280\u20131283 (1986).","journal-title":"J. Urol."},{"key":"BFnrneph2014137_CR193","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.ajhg.2008.02.017","volume":"82","author":"C Bergmann","year":"2008","unstructured":"Bergmann, C. et al. Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia. A m. J. Hum. Genet. 82, 959\u2013970 (2008).","journal-title":"A m. J. Hum. Genet."},{"key":"BFnrneph2014137_CR194","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1006\/geno.1996.4567","volume":"40","author":"PM Janaswami","year":"1997","unstructured":"Janaswami, P. M. et al. Identification and genetic mapping of a new polycystic kidney disease on mouse chromosome 8. Genomics 40, 101\u2013107 (1997).","journal-title":"Genomics"},{"key":"BFnrneph2014137_CR195","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1073\/pnas.97.1.217","volume":"97","author":"P Upadhya","year":"2000","unstructured":"Upadhya, P., Birkenmeier, E. H., Birkenmeier, C. S. & Barker, J. E. Mutations in a NIMA-related kinase gene, Nek1, cause pleiotropic effects including a progressive polycystic kidney disease in mice. Proc. Natl Acad. Sci. USA 97, 217\u2013221 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2014137_CR196","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ajhg.2010.12.004","volume":"88","author":"C Thiel","year":"2011","unstructured":"Thiel, C. et al. NEK1 mutations cause short-rib polydactyly syndrome type majewski. Am. J. Hum. Genet. 88, 106\u2013114 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2014137_CR197","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tjog.2012.04.018","volume":"51","author":"CP Chen","year":"2012","unstructured":"Chen, C. P. et al. Prenatal diagnosis and molecular genetic analysis of short rib-polydactyly syndrome type III (Verma-Naumoff) in a second-trimester fetus with a homozygous splice site mutation in intron 4 in the NEK1 gene. Taiwan. J. Obstet. Gynecol. 51, 266\u2013270 (2012).","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"BFnrneph2014137_CR198","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/ki.1993.151","volume":"43","author":"A Atala","year":"1993","unstructured":"Atala, A., Freeman, M. R., Mandell, J. & Beier, D. R. Juvenile cystic kidneys (jck): a new mouse mutation which causes polycystic kidneys. Kidney Int. 43, 1081\u20131085 (1993).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR199","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1126\/science.8191288","volume":"264","author":"JH Moyer","year":"1994","unstructured":"Moyer, J. H. et al. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science 264, 1329\u20131333 (1994).","journal-title":"Science"},{"key":"BFnrneph2014137_CR200","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1242\/dev.127.11.2347","volume":"127","author":"NS Murcia","year":"2000","unstructured":"Murcia, N. S. et al. The oak ridge polycystic kidney (orpk) disease gene is required for left-right axis determination. Development 127, 2347\u20132355 (2000).","journal-title":"Development"},{"key":"BFnrneph2014137_CR201","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/ki.1993.79","volume":"43","author":"BD Cowley","year":"1993","unstructured":"Cowley, B. D. et al. Autosomal-dominant polycystic kidney disease in the rat. Kidney Int. 43, 522\u2013534 (1993).","journal-title":"Kidney Int."},{"key":"BFnrneph2014137_CR202","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/hmg\/6.4.609","volume":"6","author":"MT Bihoreau","year":"1997","unstructured":"Bihoreau, M. T. et al. Location of the first genetic locus, PKDr1, controlling autosomal dominant polycystic kidney disease in Han:SPRDcy\/+ rat. Hum. Mol. Genet. 6, 609\u2013613 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014137_CR203","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/ng.2681","volume":"45","author":"S Hoff","year":"2013","unstructured":"Hoff, S. et al. ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. Nat. Genet. 45, 951\u2013956 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014137_CR204","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1681\/ASN.V11122272","volume":"11","author":"J Nauta","year":"2000","unstructured":"Nauta, J. et al. New rat model that phenotypically resembles autosomal recessive polycystic kidney disease. J. Am. Soc. Nephrol. 11, 2272\u20132284 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014137_CR205","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ng1713","volume":"38","author":"UM Smith","year":"2006","unstructured":"Smith, U. M. et al. The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber syndrome and the wpk rat. Nat. Genet. 38, 191\u2013196 (2006).","journal-title":"Nat. Genet."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2014.137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2014.137","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2014.137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:43:37Z","timestamp":1684471417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2014.137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,19]]},"references-count":205,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["BFnrneph2014137"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2014.137","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,19]]},"assertion":[{"value":"19 August 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}